81_95_ordin Nr 1301-500 Partea II

8/19/2019 81_95_ordin Nr 1301-500 Partea II

1/485

ORDIN Nr. 1301/500 din 11 iulie 2008 - Partea a II-a pentru aprobarea protocoalelor terapeutice privind prescrierea edica entelor a!erendenu irilor co une interna"ionale prev#$ute %n &ista cuprin$'nd denu irile co uninterna"ionale corespun$#toare edica entelor de care bene!icia$# asi(ura"ii) cu saucontribu"ie personal#) pe ba$# de prescrip"ie edical#) %n siste ul de asi(ur#ri socs#n#tate) aprobat# prin*ot#r'rea +uvernului nr. ,20/2008

I N INI R4& N 6II P47&I - Nr. 1301 9 9 N96ION9&9 D 9 I+4R RI D N 9 - Nr. 500P47&I 9 :N ONI OR4& O;I I9& NR. 531 bis din 15 iulie 2008

Ordinul nr. 1.301/500/2008 a !ost publicat %n onitorul O!icial al Ro 'niei) ParteI) nr. 531 din 15 iulie 2008 0? alin. @1 lit. ( 3 din &e(ea nr. A5/200? privind re!or a %n do enius#n#t#"ii) cu odi!ic#rile din *ot#r'rea +uvernului nr. ,20/2008 pentru aprobarea &istei cuprin$'nddenu irile co une interna"ionale corespun$#toare edica entelor de care bene!icia$asi(ura"ii) cu sau !#r# contribu"ie personal#) pe ba$# de prescrip"ie edical#) %n si

de asi(ur#ri sociale de s#n#tateB %n te eiulart. 281 alin. @2 din &e(ea nr. A5/200?) cu odi!ic#rile din *ot#r'rea +uvernului nr. 8?2/200? privind or(ani$are!unc"ionarea inisterului #n#t#"ii Publice) cu odi!ic#rile


2/485

protocoale terapeutice) prev#$ute %naneCele nr. 1


3/485

- %n con!or itate cu prevederileontractului-cadru privind condi"iile acord#riiasisten"ei edicale %n cadrul siste ului de asi(ur#ri sociale de s#n#tate pentru anul aprobat prin *ot#r'rea +uvernului nr. 32>/2008) cu odi!ic#rile


4/485

______________________________________________________________________________| 1 |A02BA02| RANITIDINUM | ||_______|_______|____________________________________________|_________________|

NOTĂ: Ter !" #e er #"$ re " &e$'"e" $( )e*"$+, $ er !.*+r" re,("e /( /e#ere

" e " "'"er"" r e (*(" (*$er(*(" !e! "$ $( $e3 e#"$ e 4 Se !*"$( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6" $+ $e r '""*+r

$+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A02BA02 RANITIDINUM CAPS4 1 0 ULCORAN 1 0 EUROP)ARM SA

A02BA02 RANITIDINUM COMPR4 1 0

RANITIDIN 1 0 ARENA ;ROUP SARANITIDINA 1 0 1 0 MA;ISTRA CO ?ELLCOME U@ LTD4

A02BA02 RANITIDINUM SOL4 IN 4 2 8 *ARNETIN 2 8 * MEDOC)EMIE LTD4=ANTAC SOLUŢIE IN ECTABILĂ 2 8 * ;LA>O ?ELLCOME U@ LTD4

A02BA02 RANITIDINUM COMPR4 FILM4 00 RANITIDIN 00 00 AC )ELCOR SRLRANITIDINA 00 00 FILDAS TRADIN; SRLRANITIDINA LP) 00 00 LABORMED P)ARMA SA________________________________________________________________________________

______________________________________________________________________________| 2 |A02BA0 | FAMOTIDINUM | ||_______|_______|____________________________________________|_________________|



$+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________


5/485

CONCENTRAŢIE FIRMA________________________________________________________________________________A02BA0 FAMOTIDINUM COMPR4 FILM4 10 FAMODAR ABR 10 DAR AL DA?A P)ARMA S4R4L4

A02BA0 FAMOTIDINUM COMPR4 FILM4 20 FAMODAR 20 20 DAR AL DA?A P)ARMA S4R4L4FAMODIN 20 20 AC )ELCOR P)ARMA SRLFAMOTA@ 20 SEDICO IMPE> S4R4L4

UAMATEL R 20 20 ;EDEON RIC)TER PLC

A02BA0 FAMOTIDINUM COMPR4 FILM4 20 FAMODAR 20 20 DAR AL DA?A P)ARMA S4R4LFAMODIN 20 20 AC )ELCOR P)ARMA SRLFAMOTA@ 20 SEDICO IMPE> S4R4L4


A02BA0 FAMOTIDINUM LIOF4 SOLV4 PT4 SOL4 IN 4 20


A02BA0 FAMOTIDINUM COMPR4 FILM4 G0 FAMODAR G0 G0 DAR AL DA?A P)ARMA SRLFAMODIN G0 G0 AC )ELCOR P)ARMA SRLFAMOTA@ G0 SEDICO IMPE> S4R4L4FAMOTIDINA =ENTIVA G0 G0 =ENTIVA S4A4;ASTROSIDIN G0 EC=ACIBASI P)ARMACEUTICALS S4R4L4

UAMATEL R G0 G0 ;EDEON RIC)TER PLC________________________________________________________________________________

______________________________________________________________________________| |A02BA0G| NI=ATIDINUM | ||_______|_______|____________________________________________|_________________|



$+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A02BA0G NI=ATIDINUM CAPS4 1 0 NI=ATIDIN 1 0 1 0 VIM SPECTRUM SRLNI=ATIDIN ALAROP)ARM 1 0 1 0 LAROP)ARM S4R4L4________________________________________________________________________________

______________________________________________________________________________| G |A02BC01| OMEPRA=OLUM | ||_______|_______|____________________________________________|_________________|

NOTĂ:


6/485

Ter !" #e er #"$ re " &e$'"e" $( )e*"$+, $ er !.*+r" re,("e /( /e#ere" e " "'"er"" r e (*(" (*$er(*(" !e! "$ $( $e3 e#"$ e 4 Se !*"$

( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6" $+ $e r '""*+r$+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A02BC01 OMEPRA=OLUM CAPS4 ;ASTRORE=4 10 ORTANOL R S 10 LE@ P)ARMACEUTICALS D4D4

Pre3$r"ere *" " : B+ * #e re&*(H 3 r+-e3+& " 4 Se !*"$ !e r( + e #e ( "r"*e $+ er$" *e 6" &+r e*e & r $e( "$e *e$+ $e r '"e" #e 10 4

A02BC01 OMEPRA=OLUM COMPR4 FILM4 ;ASTRORE=4 10 LOSEC MUPS 10 10 ASTRA=ENECA AB

A02BC01 OMEPRA=OLUM CAPS4 ;ASTRORE=4 20 )ELICID 20 20 =ENTIVA ASOMEPRA=OL 20 20 ;EDEON RIC)TER ROMANIA SAOMEPRA=OL BIOFARM 20 20 BIOFARM S4A4OMEPRA=OL LP) 20 20 LABORMED P)ARMA SAOMEPRA=OL TERAPIA 20 20 TERAPIA S4A4OMERAN 20 20 EUROP)ARM SAOME= 20 DR4 REDD JS LABORATORIESORTANOL R 20 20 LE@ P)ARMACEUTICALS D4D4ULTOP 20 @R@A D4D4

Pre3$r"ere *" " : B+ * #e re&*(H 3 r+-e3+& " Pre3$r"ere *" " : S$*er+#er " e3+& (*("4 Pre3$r"ere *" " : S" #r+ (* =+**" er - E**"3+ Pre3$r"ere *" " : Tr e (* (*$er(*(" 3 r"$ 6" #(+#e *4 Pre3$r"ere *" " : Pr+&"* H" (*$er(*(" 3 r+ - #(+#e * * ! $"e '""

r e $( AINS !e er e *( 6" $ re !re7" & $ +r" #e r"3$ 3 r+" e3 " *4

NOTĂ: Se !*"$ !e r( + e #e ( "r"*e $+ er$" *e 6" &+r e*e & r $e( "$e$+re3!( 7 + re $+ $e r '""*+r #e 20 4

A02BC01 OMEPRA=OLUM CAPS4 ENTER4 20 RISE@ 20 ;ULF P)ARMACEUTICAL INDUSTRIES S4R4L4

A02BC01 OMEPRA=OLUM COMPR4 FILM4 ;ASTRORE=4 20 LOSEC MUPS 20 20 ASTRA=ENECA ABOMEDAR R 20 DAR AL DA?A P)ARMA S4R4L4

A02BC01 OMEPRA=OLUM CAPS4 ;ASTRORE=4 G0 OMERAN G0 G0 EUROP)ARM SAORTANOL R G0 LE@ P)ARMACEUTICALS D4D4ULTOP G0 @R@A D4D4 NOVO MESTO

Pre3$r"ere *" " : B+ * #e re&*(H 3 r+-e3+& " Pre3$r"ere *" " : S$*er+#er " e3+& (*("4


7/485

Pre3$r"ere *" " : S" #r+ (* =+**" er-E**"3+ Pre3$r"ere *" " : Tr e (* (*$er(*(" 3 r"$ 6" #(+#e *4

NOTĂ: Se !*"$ !e r( + e #e ( "r"*e $+ er$" *e 6" &+r e*e & r $e( "$e$+re3!( 7 + re $+ $e r '""*+r #e G0 4

________________________________________________________________________________

______________________________________________________________________________| |A02BC0 | LANSOPRA=OLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A02BC0 LANSOPRA=OLUM CAPS4 ;ASTRORE=4 1 LEVANT 1 1 RANBA> U@ LTD4

Pre3$r"ere *" " : B+ * #e re&*(H 3 r+-e3+& "

A02BC0 LANSOPRA=OLUM CAPS4 ;ASTRORE=4 0 LAN=AP 0 0 DR4 REDD JS LABORATORIESLAN=UL 0 @R@A D4D4 NOVO MESTOLEVANT 0 0 RANBA> U@ LTD4

Pre3$r"ere *" " : B+ * #e re&*(H 3 r+-e3+& " Pre3$r"ere *" " : S" #r+ (* =+**" er-E**"3+ 4 Pre3$r"ere *" " : Tr e (* (*$er(*(" 3 r"$ 6" #(+#e *4 Pre3$r"ere *" " : Pr+&"* H" (*$er(*(" 3 r+-#(+#e * * ! $"e '""

r e $( AINS !e er e *( 6" $ re !re7" & $ +r" #e r"3$ 3 r+" e3 " *4

NOTĂ: Se !*"$ !e r( + e #e ( "r"*e $+ er$" *e 6" &+r e*e & r $e( "$e$+re3!( 7 + re $+ $e r '"e" #e 0 4

________________________________________________________________________________

______________________________________________________________________________| K |A0 AA0G| MEBEVERINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 AA0G MEBEVERINUM CAPS4 ELIB4 PREL4 200 DUSPATALIN R 200 200 SOLVA P)ARMACEUTICALS BV________________________________________________________________________________

______________________________________________________________________________| |A0 AA0 | TRIMEBUTINUM | ||_______|_______|____________________________________________|_________________|


8/485

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 AA0 TRIMEBUTINUM COMPR4 100 COLOBUTINE R 100 LAB4 FOURNIER SACOLPERIN 100 100 ;EDEON RIC)TER ROMANIA S4A4PROMEBUTIN R 100 100 TERAPIA SATRIMEBUTIN 100 100 MA;ISTRA C < C

A0 AA0 TRIMEBUTINUM COMPR4 FILM4 100 DEBRIDAT 100 100 PFI=ER EUROPE MA EEI;

A0 AA0 TRIMEBUTINUM ;RAN4 PT4 SUSP4 ORALĂ 2G 8 *DEBRIDAT 2G 8 * PFI=ER EUROPE MA EEI;

A0 AA0 TRIMEBUTINUM COMPR4 FILM4 ELIB4 00 PREL4

IBUTIN R 00 00 =ENTIVA SA________________________________________________________________________________

______________________________________________________________________________| |A0 AD01| PAPAVERINI ) DROC)LORIDUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 AD01 PAPAVERINI COMPR4 100 ) DROC)LORIDUMPAPAVERINA 100 100 SINTOFARM SA

A0 AD01 PAPAVERINI COMPR4 200 ) DROC)LORIDUMPAPAVERINA 200 FARMACOM SA________________________________________________________________________________

______________________________________________________________________________| 9 |A0 FA01| METOCLOPRAMIDUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 FA01 METOCLOPRAMIDUM COMPR4 10 METOCLOPRAMID 10 SLAVIA P)ARM SRLMETOCLOPRAMID 10 10 TERAPIA SAN-METOCLOPRAMID 10 MEDUMAN SA

A0 FA01 METOCLOPRAMIDUM SIROP 1 8 *METOCLOPRAMID BIOFARM 1 8 * BIOFARM S4A4


9/485

1 8 *

A0 FA01 METOCLOPRAMIDUM SOL4 IN 4 8 *METOCLOPRAMID 10 8 * TERAPIA SA

A0 FA01 METOCLOPRAMIDUM PIC4 ORALE - SOL4 8 *METOCLOPRAMID 8 * BIOFARM SA________________________________________________________________________________

______________________________________________________________________________| 10 |A0 FA0 | DOMPERIDONUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 FA0 DOMPERIDONUM COMPR4 FILM4 10 MOTILIUM 10 ANSSEN P)ARMACEUTICA NV

MOTILIUM 10 10 TERAPIA SA________________________________________________________________________________

______________________________________________________________________________| 11 |A0 AA02| ACIDUM URSODEO> C)OLICUM | ||_______|_______|____________________________________________|_________________|

NOTĂ: N( 3e / !re3$r"e re " $+ !e 3 !e r( r e (* *" " 7e" ,"*" re4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 AA02 ACIDUM CAPS4 2 0 URSODEO> C)OLICUMURSOFAL@ R 2 0 DR4 FAL@ P)ARMA ;MB)URSOSAN 2 0 PRO4 MED4 CS PRA)A AS________________________________________________________________________________

______________________________________________________________________________| 12 |A0KAD11| LACTULOSUM | ||_______|_______|____________________________________________|_________________|

Pre3$r"ere *" " : Tr e (* e $e& *+! "e" $r+ "$e !+r +-3"3 e "$e Tr e (* $+ 3 "! '"e" * ! $"e '"" e+!* 7"$"4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0KAD11 LACTULOSUM LIC)ID ORAL KK4 %DUP)ALAC R KK4 % SOLVA P)ARMACEUTICALS BV

A0KAD11 LACTULOSUM SIROP KK4 %


10/485

LACTULOSE AL SIROP KK4 % ALIUD P)ARMA ;MB) < CO4@;

A0KAD11 LACTULOSUM SOL4 ORALĂ K 0 8 *LAEVOLAC K 0 8 * K 0 8 * FRESENIUS @ABI AUSTRIA ;MB)

A0KAD11 LACTULOSUM SIROP KK4 %LACTULOSE AL SIROP KK4 % ALIUD P)ARMA ;MB) < CO4@;


A0KAD11 LACTULOSUM SIROP KK4 %LACTULOSE AL SIROP KK4 % ALIUD P)ARMA ;MB) < CO4@;


A0KAD11 LACTULOSUM LIC)ID ORAL KK4 %DUP)ALAC R KK4 % SOLVA P)ARMACEUTICALS BV

A0KAD11 LACTULOSUM SIROP K %LACTULOSE K % E4I4P4I4CO4 MED S4R4L4________________________________________________________________________________

______________________________________________________________________________| 1 |A0 AA02| N STATINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 AA02 N STATINUM COMPR4 FILM4 004000 ("NISTATINA 004000 (" ANTIBIOTICE SA

A0 AA02 N STATINUM COMPR4 FILM4 004000 ("STAMICIN R 004000 U4I4 004000 (" =ENTIVA SA________________________________________________________________________________

______________________________________________________________________________| 1G |A0 EC01| SULFASALA=INUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 EC01 SULFASALA=INUM COMPR4 FILM4 00 SALA=IDIN 00 AC )ELCOR SRL

A0 EC01 SULFASALA=INUM COMPR4 FILM4 ;ASTRORE=4 00 SULFASALA=IN EN 00 @R@A D4D4 NOVO MESTO


11/485

________________________________________________________________________________

______________________________________________________________________________| 1 |A0 EC02| MESALA=INUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________A0 EC02 MESALA=INUM SUPO=4 1 PENTASA 1 FERRIN; A8S

Pre3$r"ere *" " : E!"3+# $( #e !r+$ " (*$er "/ &+r +#er 4

NOTĂ: A ( 3e # " "3 r r e (* ,+*"" Cr+ 4

A0 EC02 MESALA=INUM COMPR4 ;ASTRORE=4 2 0

SALOFAL@ 2 0 COMPRIMATE 2 0 DR4 FAL@ P)ARMA ;MB);ASTRORE=ISTENTE

C+# re3 r"$'"e 1 0 : C+*" (*$er "/ 3+$" $( "!er3e 3","*" e *3(*&+ "#e C+# re3 r"$'"e 1 09: C+*" (*$er "/ 3+$" $( " +*er ' * 3(*& 3 * 7" ( C+# re3 r"$'"e 22K : B+ * Cr+ $ 7(* $ re eH"3 "!er3e 3","*" e *3(*&+ "#e C+# re3 r"$'"e 22K9: B+ * Cr+ $ 7(* $ re eH"3 " +*er ' *3(*& 3 * 7" (

A0 EC02 MESALA=INUM SUPO=4 2 0 SALOFAL@ R 2 0 2 0 DR4 FAL@ P)ARMA ;MB)

Pre3$r"ere *" " : E!"3+# $( #e !r+$ " (*$er "/ &+r +#er

A0 EC02 MESALA=INUM SUSP4 RECTALĂ G 8K0 *SALOFAL@ G 8K0 * G 8K0 * DR4 FAL@ P)ARMA ;MB)

C+# re3 r"$'"e 1 0 : E!"3+# $( #e $+*" (*$er "/ &+r +#er

A0 EC02 MESALA=INUM COMPR4 ELIB4 PREL4 00 PENTASA 00 FERRIN; A8S


A0 EC02 MESALA=INUM COMPR4 ;ASTRORE=4 00 SALOFAL@ 00 COMPRIMATE 00 DR4 FAL@ P)ARMA ;MB);ASTRORE=ISTENTE


12/485


A0 EC02 MESALA=INUM SUPO=4 00 SALOFAL@ R 00 00 DR4 FAL@ P)ARMA ;MB)

Pre3$r"ere *" " : E!"3+# $( #e !r+$ " (*$er "/ &+r +#er

________________________________________________________________________________

______________________________________________________________________________| 1K |B01AA0 | ACENOCUMAROLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________B01AA0 ACENOCUMAROLUM COMPR4 2 TROMBOSTOP 2 2 TERAPIA SA

B01AA0 ACENOCUMAROLUM COMPR4 G SINTROM R G NOVARTIS P)ARMA ;MB)________________________________________________________________________________

______________________________________________________________________________| 1 |B01AC0 | TICLOPIDINUM 1 | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________B01AC0 TICLOPIDINUM COMPR4 FILM4 2 0 IPATON 2 0 E;IS P)ARMACEUTICALS PLCTICLID R 2 0 2 0 SANOFI-S NT)ELABO FRANCETICLODIN 2 0 AC )ELCOR SRLTICLOPIDIN SANDO= 2 0 )E>AL A;

C+# re3 r"$'"e 1 19: Pre/e '" re$(re e" $$"#e (*(" / 3$(* r "3$ "e "$ 3 ( $$"#e (*(" "3$ e "$ r 7" +r * ! $"e '"" $( "3 +r"$ #e e!"3+ #e "3$ "e "$e$ere,r+/ 3$(* re " !(* er !"e" $( #+7e re#(3e #e 3!"r"

C+# re3 r"$'"e 1 20: Pre/e '" re$(re 'e" $$"#e (*(" / 3$(* r "3$ "e "$ 3 ( $$"#e (*(" "3$ e "$ r 7" +r * ! $"e '"" * $ re er !" $( #+7e re#(3e #e3!"r" !re7" ( r"3$ +r " $$e! ,"* #e 3Q er re 3 r+" e3 " *

C+# re3 r"$'"e 1 21: Pre/e '" re$(re 'e" $$"#e (*(" / 3$(* r "3$ "e "$ 3 ( $$"#e (*(" "3$ e "$ r 7" +r * ! $"e '"" $( "3 +r"$ #e re $'"e &"* $ "$ 5

(r "$ r"e 3 ( 3 ,r+ 6"$ #e$(r3 #e G +re #e * # " "3 r re #e 3!"r" 5 *'"3 *"$"* '" 3 ( AINS


13/485

Ne( r+!e " 3e/er e3 e ( e&e$ #/er3 $+ ( !r" e*e *( " #e er !"e4M+ " +r"7 re e +*+ "$ 3e " !( e * $e!( (* r e (*(" 6" !+" * &"e$ re#+( 3 ! Q " !r" e*e ! r( *( " #e r e 4

________________________________________________________________________________

______________________________________________________________________________| 1 |B02BA01| P) TOMENADIONUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________B02BA01 P) TOMENADIONUM SOL4 IN 4 10 8 *FITOMENADION 10 8 * 10 8 * TERAPIA SA________________________________________________________________________________

______________________________________________________________________________

| 19 |B0 AA0 | FERROSI SULFAS | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________B0 AA0 FERROSI SULFAS COMPR4 ELIB4 PREL4 10 FERRO;RADUMET R 10 TEOFARMA SRL

B0 AA0 FERROSI SULFAS DRA 4 ELIB4 PREL4 0 TARD FERON 0 0 LAB4 PIERRE FABRE

B0 AA0 FERROSI SULFAS COMPR4 FILM4 ELIB4 PREL4FERRO-;RADUMET POLIP)ARMA INDUSTRIES S4R4L4________________________________________________________________________________

______________________________________________________________________________| 20 |B0 AB0 | COMPLE> DE )IDRO>ID DE FER III | || | | POLIMALTO=AT | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________B0 AB0 COMPLE> DE )IDRO>ID COMPR4 MAST4 100 DE FER III POLIMALTO=ATMALTOFER 100 VIFOR FRANCE SA

B0 AB0 COMPLE> DE )IDRO>ID SIROP 10 8 * DE FER III


14/485

POLIMALTO=ATFERRUM )AUSMANN R 10 8 * VIFOR FRANCE SA

B0 AB0 COMPLE> DE )IDRO>ID SIROP 0 8 * DE FER III POLIMALTO=ATFER;LUROM 0 8 * 0 8 * BIOFARM S4A4

B0 AB0 COMPLE> DE )IDRO>ID PICĂTURI ORALE - SOL4 % DE FER III POLIMALTO=ATP)ARMA-FERRUM R % TERAPIA SA

B0 AB0 COMPLE> DE )IDRO>ID PICĂTURI ORALE - SOL4 0 8 * DE FER III POLIMALTO=ATFERRUM )AUSMANN R 0 8 * VIFOR FRANCE SA________________________________________________________________________________

______________________________________________________________________________

| 21 |B0 AEN1| COMBINAŢII FERROSI SULFAS ACIDUM | || | | ASCORBICUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________B0 AEN1 COMBINAŢII FERROSI COMPR4 FILM4 SULFAS ACIDUM ASCORBICUMSORBIFER DURULES E;IS P)ARMACEUTICALS LTD4________________________________________________________________________________

______________________________________________________________________________| 22 |B0 BB01| ACIDUM FOLICUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________B0 BB01 ACIDUM FOLICUM COMPR4 FILM4 ACIFOL =ENTIVA SA________________________________________________________________________________

______________________________________________________________________________| 2 |C01AA0 | DI;O>INUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________


15/485

C01AA0 DI;O>INUM SOL4 ORALĂ 040 8 *LANO>IN SOLUŢIE ORALĂ 040 8 * T)E ?ELLCOME FOUNDATION LTD4

C01AA0 DI;O>INUM COMPR4 042 DI;O>IN 052 052 =ENTIVA SA

C01AA0 DI;O>INUM SOL4 IN 4 04 8 *DI;O>IN 05 82 * 05 8 * =ENTIVA SA________________________________________________________________________________

______________________________________________________________________________| 2G |C01BA01| C)INIDINI SULFAS | ||_______|_______|____________________________________________|_________________|


C01BA01 C)INIDINI SULFAS COMPR4 200 C)INIDINA LAROP)ARM 200 200 LAROP)ARM SRLC)INIDINA SULFAT 200 200 ARENA ;ROUP SA________________________________________________________________________________

______________________________________________________________________________| 2 |C01BC0 | PROPAFENONUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C01BC0 PROPAFENONUM COMPR4 1 0 PROPAFENONA 1 0 1 0 ARENA ;ROUP SA

C01BC0 PROPAFENONUM COMPR4 FILM4 1 0 PROPAFENON AL 1 0 1 0 ALIUD R P)ARMA ;MB) < CO4@;PROPAFENON SANDO= 1 0 1 0 )E>AL A;R TMONORM R 1 0 ABBOTT ;MB) < CO4@;

C01BC0 PROPAFENONUM SOL4 IN 4 0 820 *R TMONORM 0 820 * ABBOTT ;MB) < CO4@;________________________________________________________________________________

______________________________________________________________________________| 2K |C01BD01| AMIODARONUM | ||_______|_______|____________________________________________|_________________|

Pre3$r"ere *" " : Tr e (* (*,(r r"*+r #e r" 3e/ere $ re ( r 3!( # * * e er !"" 3 ( $Q # * e " r" "$e ( !+ &" &+*+3" e: " r" "" 3+$" e 3" #r+ (*(" ?+*&& - P r " 3+ - ? " e , &*( er8&",r"* '"e r" * 5 ( $" $Q # * e " r" "$e ( !+ &" &+*+3" e $ + e " r" ""*e ! r+H"3 "$e5 " $*(7Q # "$ r#""


16/485

3(!r /e r"$(* re5 "$ r#"" /e r"$(* re 6" +# *e5 &",r"* '"e /e r"$(* r 5 ( $" $Q # * e " r" "$e ( !+ &" &+*+3" e4 EH"3 #+/e7" $ "+# r+ !+ e !r+#($e +H"$" e &re$/e 6" !+ e '" *3e/er 4 Se re$+ # + " +r"7 re !er"+#"$ &( $'""*+r e! "$e 6" "r+"#"e e4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C01BD01 AMIODARONUM COMPR4 200 AMIODARONA 200 200 ARENA ;ROUP SAAMIODARONA LP) 200 200 LABORMED P)ARMA SADARITMIN R 200 200 ;EDEON RIC)TER ROMANIA SASEDACORON R 200 EBE?E P)ARMA ;MB) NF;4 @;

C01BD01 AMIODARONUM COMPR4 DIVI=4 200

CORDARONE 200 200 SANOFI-AVENTIS FRANCE________________________________________________________________________________

______________________________________________________________________________| 2 |C01DA02| NITRO;L CERINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C01DA02 NITRO;L CERINUM SPRA SUBLIN;UAL 04G 8#+7NITROMINT 04G 8#+7 E;IS P)ARMACEUTICALS P4L4C4

NOTĂ: S!r .(* ( re,("e " * 4

C01DA02 NITRO;L CERINUM COMPR4 SUBLIN;4 04 NITRO;LICERINA 05 04 =ENTIVA SA

C01DA02 NITRO;L CERINUM COMPR4 ELIB4 PREL4 24K NITROMINT 25K 24K E;IS P)ARMACEUTICALS LTD4

C01DA02 NITRO;L CERINUM SIST4 TERAP4 TRANSDERM4 2 NITRODERM R TTS 2 NOVARTIS P)ARMA ;MB)________________________________________________________________________________

______________________________________________________________________________| 2 |C01DA0 | ISOSORBIDI DINITRAS | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA


17/485


18/485

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C01EB1 TRIMETA=IDINUM CAPS4 20 TRIMETA=IDIN 20 20 VIM SPECTRUM SRL

C01EB1 TRIMETA=IDINUM COMPR4 FILM4 20 DILATAN 20 20 TERAPIA SAMODU>IN R 20 20 ;EDEON RIC)TER ROM NIA SAPREDO=ONE 20 20 O=ONE LABORATORIES LTD4PREDUCTAL R 20 LES LAB4 SERVIER IND4TRIMETA=IDINA LP) R 20 20 LABORMED P)ARMA SATRIVEDON 20 20 CIPLA U@ LIMITED

C01EB1 TRIMETA=IDINUM DRA 4 20 TRIMETA=IDINA 20 20 TERAPIA SA

C01EB1 TRIMETA=IDINUM COMPR4 FILM4 ELIB4

MODIF4DILATAN MR TERAPIA SAPREDUCTAL MR LES LAB4 SERVIER IND4TRIMETA=IDINA LP) R LABORMED P)ARMA SA________________________________________________________________________________

______________________________________________________________________________| 2 |C02AB01| MET) LDOPUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C02AB01 MET) LDOPUM COMPR4 2 0 DOPE; T 2 0 E;IS P)ARMACEUTICALS PLC________________________________________________________________________________

______________________________________________________________________________| |C02AC01| CLONIDINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C02AC01 CLONIDINUM COMPR4 041 CLONIDINA 051 041 ARENA ;ROUP SACLONIDINA SINTOFARM 051 041 SINTOFARM SA________________________________________________________________________________

______________________________________________________________________________| G |C02CA0G| DO>A=OSINUM | ||_______|_______|____________________________________________|_________________|


19/485

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C02CA0G DO>A=OSINUM COMPR4 1 DO>A=OSIN 1 MEDOC)EMIE 1 MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL 1 1 ALIUD R P)ARMA ;MB) < CO4@;@AMIREN 1 @R@A D4D4 NOVO MESTOMA;UROL 1 MEDOC)EMIE LTD4

C02CA0G DO>A=OSINUM COMPR4 2 DO>A=OSIN 2 MEDOC)EMIE 2 MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL 2 2 ALIUD R P)ARMA ;MB) < CO4@;DO>A=OSIN SANDO= 2 2 )E>AL A;@AMIREN 2 @R@A5 D4D4 NOVO MESTOMA;UROL 2 MEDOC)EMIE LTD4

C02CA0G DO>A=OSINUM COMPR4 G DO>A=OSIN G MEDOC)EMIE G MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL G G ALIUD R P)ARMA ;MB) < CO4@;@AMIREN G @R@A D4D4 NOVO MESTOMA;UROL G MEDOC)EMIE LTD4

C02CA0G DO>A=OSINUM COMPR4 ELIB4 MODIF4 G CARDURA >L G G PFI=ER )4C4P4 CORPORATION

C02CA0G DO>A=OSINUM COMPR4 FILM4 ELIB4 G PREL4@AMIREN >L G G @R@A D4D4 NOVO MESTO

C02CA0G DO>A=OSINUM COMPR4 1 DO>A=OSIN 1 MEDOC)EMIE 1 MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL 1 1 ALIUD R P)ARMA ;MB) < CO4@;@AMIREN 1 @R@A D4D4 NOVO MESTOMA;UROL 1 MEDOC)EMIE LTD4

C02CA0G DO>A=OSINUM COMPR4 2 DO>A=OSIN 2 MEDOC)EMIE 2 MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL 2 2 ALIUD R P)ARMA ;MB) < CO4@;DO>A=OSIN SANDO= 2 2 )E>AL A;@AMIREN 2 @R@A D4D4 NOVO MESTOMA;UROL 2 MEDOC)EMIE LTD4

C02CA0G DO>A=OSINUM COMPR4 G DO>A=OSIN G MEDOC)EMIE G MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL G G ALIUD R P)ARMA ;MB) < CO4@;@AMIREN G @R@A D4D4 NOVO MESTOMA;UROL G MEDOC)EMIE LTD4

C02CA0G DO>A=OSINUM COMPR4 ELIB4 MODIF4 G


20/485

CARDURA >L G G PFI=ER )4C4P4 CORPORATION

C02CA0G DO>A=OSINUM COMPR4 FILM4 ELIB4 G PREL4@AMIREN >L G G @R@A D4D4 NOVO MESTO________________________________________________________________________________

______________________________________________________________________________| |C0 AA0 | ) DROC)LOROT)IA=IDUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 AA0 ) DROC)LOROT)IA=IDUM COMPR4 2 NEFRI> 2 2 =ENTIVA SA________________________________________________________________________________

______________________________________________________________________________| K |C0 BA11| INDAPAMIDUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 BA11 INDAPAMIDUM COMPR4 FILM4 ELIB4 15 PREL4IMPAMID SR 15 15 ;EDEON RIC)TER ROMANIA S4A4INDATER SR 15 15 TERAPIA SA

C0 BA11 INDAPAMIDUM COMPR4 FILM4 ELIB4 14 PREL4INDAPAMID SR 15 LAROP)ARM 14 LAROP)ARM SRL

C0 BA11 INDAPAMIDUM COMPR4 ELIB4 PREL4 14 INDAPAMID MCC 15 14 MA;ISTRA C < C SRL

C0 BA11 INDAPAMIDUM COMPR4 FILM4 ELIB4 14 PREL4INDAPAMID LP) R 15 14 LABORMED P)ARMA SARA?EL SR 15 14 @R@A D4D4 NOVO MESTOTERTENSIF R SR 14 LES LAB4 SERVIER IND4

C0 BA11 INDAPAMIDUM COMPR4 24 IMPAMID R 25 24 ;EDEON RIC)TER ROMANIA SA

C0 BA11 INDAPAMIDUM COMPR4 FILM4 24 INDAPAMID LP) R 25 24 LABORMED P)ARMA SAINDAPAMIDE 25 24 )EMOFARM S4R4L4INDATER R 25 24 TERAPIA SA________________________________________________________________________________


21/485

______________________________________________________________________________| |C0 CA01| FUROSEMIDUM | ||_______|_______|____________________________________________|_________________|

E*e$ r+*"'"" 3er"$" re,("e 3 &"e /er"&"$ '" !er"+#"$4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 CA01 FUROSEMIDUM SOL4 IN 4 10 8 *FUROSEMID 20 82 * 10 8 * =ENTIVA SA

C0 CA01 FUROSEMIDUM COMPR4 G0 FUROSEMID ARENA G0 G0 ARENA ;ROUP S4A4FUROSEMID EEL G0 BIO EEL SRLFUROSEMID LP) G0 G0 LABORMED P)ARMA SA

FUROSEMID MCC G0 G0 MA;ISTRA C < C SRLFUROSEMID SLAVIA G0 SLAVIA P)ARM SRLFUROSEMID =ENTIVA G0 =ENTIVA SA________________________________________________________________________________

______________________________________________________________________________| |C0 DA01| SPIRONOLACTONUM | ||_______|_______|____________________________________________|_________________|

E*e$ r+*"'"" 3er"$" re,("e 3 &"e /er"&"$ '" !er"+#"$4 Fe e"*e * /Qr3 &er "* * $ re 3- " "'" r e $( 3!"r+ +* $ +

re,("e 3 " 3(r" #e$/ e #e $+ r $e!'"e4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 DA01 SPIRONOLACTONUM CAPS4 100 VEROSPIRON 100 ;EDEON RIC)TER LTD4

C0 DA01 SPIRONOLACTONUM COMPR4 2 SPIRONOLACTONA 2 2 BIO EEL SRL

C0 DA01 SPIRONOLACTONUM COMPR4 FILM4 2 ALSPIRON 2 2 AC )ELCOR P)ARMA SRLSPIRONOLACTONA 2 2 TERAPIA SA

C0 DA01 SPIRONOLACTONUM CAPS4 0 VEROSPIRON 0 ;EDEON RIC)TER LTD4

C0 DA01 SPIRONOLACTONUM COMPR4 FILM4 0 ALSPIRON 0 0 AC )ELCOR P)ARMA SRL________________________________________________________________________________


22/485

______________________________________________________________________________| 9 |C0 EB01| COMBINAŢII SPIRONOLACTONUM FUROSEMIDUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 EB01 COMBINAŢII CAPS4 SPIRONOLACTONUM FUROSEMIDUMDIURE> 0 TERAPIA SA________________________________________________________________________________

______________________________________________________________________________| G0 |C0GAD0 | PENTO>IF LLINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0GAD0 PENTO>IF LLINUM COMPR4 FILM4 ELIB4 G00 PREL4AN;IOPENT G00 G00 AC )ELCOR P)ARMA SRLPENTO>I RETARD G00 G00 TERAPIA SA

C0GAD0 PENTO>IF LLINUM DRA 4 ELIB4 PREL4 G00 TRENTAL R G00 AVENTIS P)ARMA DEUTSC)LAND ;MB)

C0GAD0 PENTO>IF LLINUM COMPR4 FILM4 ELIB4 K00 PREL4AN;IOPENT K00 K00 AC )ELCOR P)ARMA SRL________________________________________________________________________________

______________________________________________________________________________| G1 |C0 AA0 | PROPRANOLOLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 AA0 PROPRANOLOLUM COMPR4 10 N-PROPRANOLOL 10 10 SC MEDUMAN SAPROPRANOLOL 10 BIO EEL SRLPROPRANOLOL 10 10 SINTOFARM SA

C0 AA0 PROPRANOLOLUM COMPR4 G0 PROPRANOLOL G0 G0 SINTOFARM SAPROPRANOLOL EEL G0 G0 BIO EEL SRL________________________________________________________________________________


23/485

______________________________________________________________________________| G2 |C0 AA0 | SOTALOLUM | ||_______|_______|____________________________________________|_________________|

Pre3$r"ere *" " : Tr e (* r" ""*+r /e r"$(* re 3e/ere4 Tr e (* r" ""*+r 3(!r /e r"$(* re4 Se !*"$ !e r( + e #e ( "r"*e $+ er$" *e 6" &+r e*e & r $e( "$e$+re3!( 7 + re #e ( "r"" $+ ( e " er '"+ *e4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 AA0 SOTALOLUM COMPR4 1K0 ALS-SOTALOL 1K0 1K0 ALSIFCOM INTERMED SRLDAROB R 1K0 1K0 ABBOTT ;MB) < CO4@;SOTA;AMMA 1K0 1K0 ?OR?A; P)ARMA ;MB) < CO4@;SOTALOL AL 1K0 1K0 ALIUD P)ARMA ;MB) < CO4@;

C0 AA0 SOTALOLUM COMPR4 0 ALS-SOTALOL 0 0 ALSIFCOM INTERMED SRLDAROB R 0 0 ABBOTT ;MB) < CO4@;SOTA;AMMA 0 0 ?OR?A; P)ARMA ;MB) < CO4@;________________________________________________________________________________

______________________________________________________________________________| G |C0 AB02| METOPROLOLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 AB02 METOPROLOLUM COMPR4 100 BETAPROL 100 100 AC )ELCOR P)ARMA SRLBLO>AN 100 @R@A D4D4 NOVO MESTOE;ILO@ 100 100 E;IS P)ARMACEUTICALS P4L4C4METOPRO TAD 100 100 TAD P)ARMA ;MB)METOPROLOL 100 100 MA;ISTRA C < C SRLMETOPROLOL AL 100 100 ALIUD R P)ARMA ;MB) < CO4@;METOPROLOL LP) 100 100 LABORMED P)ARMA SAMETOPROLOL MEDICO UNO 100 100 MEDICO UNO P)ARMACEUTICAL S4R4L4METOPROLOL TERAPIA 100 100 TERAPIA SAVASOCARDIN R 100 100 SLOVA@OFARMA

C0 AB02 METOPROLOLUM COMPR4 ELIB4 PREL4 100 METOPROLOL RETARD 100 100 TERAPIA S4A4

C0 AB02 METOPROLOLUM COMPR4 FILM4 ELIB4 100 PREL4BETALOCR =OC 100 100 ASTRA=ENECA AB


24/485

C0 AB02 METOPROLOLUM COMPR4 FILM4 ELIB4 MOD4 190 METOSUCCINAT SANDO= 190 190 )E>AL A;

C0 AB02 METOPROLOLUM COMPR4 ELIB4 PREL4 200 VASOCARDIN R SR 200 200 =ENTIVA AS

C0 AB02 METOPROLOLUM COMPR4 2 E;ILO@ 2 2 E;IS P)ARMACEUTICALS P4L4C4METOPROLOL 2 2 ARENA ;ROUP SAMETOPROLOL LP) 2 2 LABORMED P)ARMA SAMETOPROLOL MEDICO UNO 2 2 MEDICO UNO P)ARMACEUTICAL S4R4L4

C0 AB02 METOPROLOLUM COMPR4 FILM4 ELIB4 MOD4 G 4 METOSUCCINAT SANDO= G 5 G 4 )E>AL A;

C0 AB02 METOPROLOLUM COMPR4 0 BETAPROL 0 0 AC )ELCOR P)ARMA SRLE;ILO@ 0 0 E;IS P)ARMACEUTICALS

P4L4C4METOPRO TAD 0 0 TAD P)ARMA ;MB)METOPROLOL 0 0 MA;ISTRA C < C SRLMETOPROLOL AL 0 0 ALIUD P)ARMA ;MB) < CO4@;METOPROLOL LP) 0 0 LABORMED P)ARMA SAMETOPROLOL MEDICO UNO 0 0 MEDICO UNO P)ARMACEUTICAL S4R4L4METOPROLOL TERAPIA 0 0 TERAPIA SA

C0 AB02 METOPROLOLUM COMPR4 FILM4 ELIB4 0 PREL4BETALOCR =OC 0 0 ASTRA=ENECA AB

C0 AB02 METOPROLOLUM COMPR4 FILM4 ELIB4 MOD4 9 METOSUCCINAT SANDO= 9 9 )E>AL A;________________________________________________________________________________

______________________________________________________________________________| GG |C0 AB0 | ATENOLOLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA FIRMA________________________________________________________________________________C0 AB0 ATENOLOLUM COMPR4 100 ATECOR 100 ?IN - MEDICARE LTD4ATENOCOR 100 100 AC )ELCOR SRLATENOLOL 100 100 ARENA ;ROUP SAATENOLOL LP) 100 100 LABORMED P)ARMA SA

C0 AB0 ATENOLOLUM COMPR4 FILM4 100 ATENOLOL 100 100 TERAPIA SAATENOLOL 100 MEDO 100 MEDOC)EMIE ROMANIA SRLVASCOTEN 100 MEDOC)EMIE LTD4


25/485

C0 AB0 ATENOLOLUM COMPR4 0 ATENOCOR 0 0 AC )ELCOR SRLATENOLOL 0 0 SLAVIA P)ARM SRLATENOLOL LP) 0 0 LABORMED P)ARMA SA

C0 AB0 ATENOLOLUM COMPR4 FILM4 0 ATENOLOL 0 0 TERAPIA SA________________________________________________________________________________

______________________________________________________________________________| G |C0 AB0 | BETA>OLOLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 AB0 BETA>OLOLUM COMPR4 FILM4 20 BETAC 20 MEDOC)EMIE LTD4

LO@REN 20 20 SANOFI-AVENTIS FRANCE________________________________________________________________________________

______________________________________________________________________________| GK |C0 AB0 | BISOPROLOLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 AB0 BISOPROLOLUM COMPR4 10 BISOBLOC@ 10 10 @ERI P)ARMA ;ENERICS LTD4

C0 AB0 BISOPROLOLUM COMPR4 FILM4 10 BISO;AMMA R 10 10 ?OR?A; P)ARMA ;MB) < CO4@;BISOTENS 10 10 ANTIBIOTICE SACONCOR 10 10 MERC@ @;AA

C0 AB0 BISOPROLOLUM COMPR4 FILM4 24 CONCOR COR 25 24 MERC@ @;AA

C0 AB0 BISOPROLOLUM COMPR4 BISOBLOC@ @ERI P)ARMA ;ENERICS LTD4

C0 AB0 BISOPROLOLUM COMPR4 FILM4 BISO;AMMA R ?OR?A; P)ARMA ;MB) < CO4@;BISOTENS ANTIBIOTICE SACONCOR MERC@ @;AA________________________________________________________________________________

______________________________________________________________________________| G |C0 A;02| CARVEDILOLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________


26/485

DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 A;02 CARVEDILOLUM COMPR4 125 CARVEDILOL SANDO= 125 )E>AL A;

C0 A;02 CARVEDILOLUM COMPR4 124 ATRAM 124 124 =ENTIVA ASCARVEDILOL 125 124 VIM SPECTRUM SRLCARVEDILOL )ELCOR 125 124 AC )ELCOR P)ARMA SRLCARVEDILOL LP) 125 124 LABORMED P)ARMA SACARVEDILOL TEVA 125 124 TEVA P)ARMACEUTICAL S4R4L4COR OL R 124 @R@A D4D4DILATREND R 125 124 ROC)E ROMANIA S4R4L4TALLITON R 125 124 E;IS P)ARMACEUTICALS LTD4

C0 A;02 CARVEDILOLUM COMPR4 FILM4 124 CARVEDI;AMMA 125 124 ?OR?A; P)ARMA ;MB) < CO4@;

C0 A;02 CARVEDILOLUM COMPR4 2 ATRAM 2 2 =ENTIVA ASCARVEDILOL )ELCOR 2 2 AC )ELCOR P)ARMA SRLCARVEDILOL LP) 2 2 LABORMED P)ARMA SACARVEDILOL SANDO= 2 )E>AL A;CARVEDILOL TEVA 2 2 TEVA P)ARMACEUTICAL S4R4L4COR OL R 2 @R@A D4D4DILATREND R 2 2 ROC)E ROMANIA S4R4L4TALLITON R 2 2 E;IS P)ARMACEUTICALS LTD4

C0 A;02 CARVEDILOLUM COMPR4 FILM4 2 CARVEDI;AMMA 2 2 ?OR?A; P)ARMA ;MB) < CO4@;

C0 A;02 CARVEDILOLUM COMPR4 412 COR OL R 512 412 @R@A D4D4

C0 A;02 CARVEDILOLUM COMPR4 K42 ATRAM K42 K42 =ENTIVA ASCARVEDILOL K52 K42 VIM SPECTRUM SRLCARVEDILOL LP) K52 K42 LABORMED P)ARMA SACARVEDILOL SANDO= K42 )E>AL A;CARVEDILOL TEVA K52 K42 TEVA P)ARMACEUTICAL S4R4L4COR OL R K42 @R@A D4D4DILATREND R K52 K42 ROC)E ROMANIA S4R4L4TALLITON K52 K42 E;IS P)ARMACEUTICALS LTD4

C0 A;02 CARVEDILOLUM COMPR4 FILM4 K42 CARVEDI;AMMA K52 K42 ?OR?A; P)ARMA ;MB) < CO4@;________________________________________________________________________________

______________________________________________________________________________| G |C0 CA01| AMLODIPINUM | ||_______|_______|____________________________________________|_________________|



27/485

CONCENTRAŢIE FIRMA________________________________________________________________________________C0 CA01 AMLODIPINUM COMPR4 10 ALO=UR 10 10 O=ONE LABORATORIES BVAMLO TAD 10 10 TAD P)ARMA ;MB)AMLODIPIN 10 10 VIM SPECTRUM SRLAMLODIPINE-TEVA 10 10 TEVA P)ARMACEUTICAL S4R4L4AMLO)E>AL 10 10 )E>AL A;NORVASC 10 10 PFI=ER EUROPE MA EEI;STAMLO M 10 10 DR4 REDD JS LABORATORIESTENO> R 10 10 @R@A D4D4VASORE> 10 10 LABORMED P)ARMA S4A4

C0 CA01 AMLODIPINUM COMPR4 ALO=UR O=ONE LABORATORIES BVAMLO TAD TAD P)ARMA ;MB)AMLODIPIN VIM SPECTRUM SRLAMLODIPINE-TEVA TEVA P)ARMACEUTICAL S4R4L4AMLO)E>AL )E>AL A;NORVASC PFI=ER EUROPE MA EEI;

STAMLO M DR4 REDD JS LABORATORIESTENO> R @R@A D4D4VASORE> LABORMED P)ARMA S4A4________________________________________________________________________________

______________________________________________________________________________| G9 |C0 CA02| FELODIPINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 CA02 FELODIPINUM COMPR4 ELIB4 MODIF4 10 FELODIPIN AL 10 RETARD 10 ALIUD R P)ARMA ;MB) < CO4@;

C0 CA02 FELODIPINUM COMPR4 ELIB4 PREL4 10 PLENDIL 10 ASTRA=ENECA AB

C0 CA02 FELODIPINUM COMPR4 FILM4 ELIB4 10 MODIF4SISTAR 10 10 ;EDEON RIC)TER ROMANIA SA

C0 CA02 FELODIPINUM COMPR4 FILM4 ELIB4 10 PREL4AURONAL 10 10 E;IS P)ARMACEUTICALS PLCMIVARA 10 10 STADA AR=NEIMITTEL A;PRESID R 10 10 IVA>-P)ARMACEUTICALS S4R4O4

C0 CA02 FELODIPINUM COMPR4 ELIB4 MODIF4 24 FELODIPIN AL 25 RETARD 24 ALIUD R P)ARMA ;MB) < CO4@;

C0 CA02 FELODIPINUM COMPR4 ELIB4 PREL4 24


28/485

PLENDIL 24 ASTRA=ENECA AB

C0 CA02 FELODIPINUM COMPR4 FILM4 ELIB4 24 MODIF4SISTAR 25 24 ;EDEON RIC)TER ROMANIA SA

C0 CA02 FELODIPINUM COMPR4 FILM4 ELIB4 24 PREL4AURONAL 25 24 E;IS P)ARMACEUTICALS PLCPRESID R 25 24 IVA>-P)ARMACEUTICALS S4R4O4

C0 CA02 FELODIPINUM COMPR4 ELIB4 MODIF4 FELODIPIN AL RETARD ALIUD R P)ARMA ;MB) < CO4@;

C0 CA02 FELODIPINUM COMPR4 ELIB4 PREL4 PLENDIL ASTRA=ENECA AB

C0 CA02 FELODIPINUM COMPR4 FILM4 ELIB4

MODIF4SISTAR ;EDEON RIC)TER ROMANIA SA

C0 CA02 FELODIPINUM COMPR4 FILM4 ELIB4 PREL4AURONAL E;IS P)ARMACEUTICALS PLCMIVARA STADA AR=NEIMITTEL A;PRESID R IVA>-P)ARMACEUTICALS S4R4O4________________________________________________________________________________

______________________________________________________________________________| 0 |C0 CA0 | NIFEDIPINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 CA0 NIFEDIPINUM COMPR4 ELIB4 MODIF4 20 ADALAT CR 20 20 BA ER )EALT)CARE A;

C0 CA0 NIFEDIPINUM COMPR4 FILM4 ELIB4 20 PREL4ADALAT R RETARD 20 BA ER )EALT)CARE A;NIFEDIPIN RETARD TERAPIA 20 TERAPIA SA20

C0 CA0 NIFEDIPINUM DRA 4 20 EPILAT RETARD 20 E4I4P4I4CO4 MED S4R4L4

C0 CA0 NIFEDIPINUM COMPR4 ELIB4 MODIF4 0 ADALAT CR 0 0 BA ER )EALT)CARE A;

C0 CA0 NIFEDIPINUM COMPR4 ELIB4 MODIF4 20 ADALAT CR 20 20 BA ER )EALT)CARE A;


29/485

C0 CA0 NIFEDIPINUM COMPR4 FILM4 ELIB4 20 PREL4ADALAT R RETARD 20 BA ER )EALT)CARE A;NIFEDIPIN RETARD TERAPIA 20 TERAPIA SA20 ________________________________________________________________________________

______________________________________________________________________________| 1 |C0 DA01| VERAPAMILUM | ||_______|_______|____________________________________________|_________________|

E&e$ e*e #e " ", re &( $'"e" "+$ r#"$e *e $e3 (" e#"$ e 3e $( (*e 7$( $e*e *e ,e -,*+$ e*+r4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4


CONCENTRAŢIE FIRMA________________________________________________________________________________C0 DA01 VERAPAMILUM COMPR4 FILM4 ELIB4 2G0 PREL4ISOPTIN RR 2G0 ABBOTT ;MB) < CO4@;VERO;ALID R ER 2G0 2G0 IVA>-P)ARMACEUTICALS S4R4O4

C0 DA01 VERAPAMILUM COMPR4 FILM4 G0 ISOPTIN R G0 G0 ABBOTT ;MB) < CO4@;VERAPAMIL AL G0 G0 ALIUD R P)ARMA ;MB) < CO4@;

C0 DA01 VERAPAMILUM COMPR4 FILM4 0 ISOPTIN R 0 0 ABBOTT ;MB) < CO4@;VERAPAMIL AL 0 0 ALIUD R P)ARMA ;MB) < CO4@;________________________________________________________________________________

______________________________________________________________________________| 2 |C0 DB01| DILTIA=EMUM | ||_______|_______|____________________________________________|_________________|

E&e$ e*e #e " ", re &( $'"e" "+$ r#"$e *e $e3 (" e#"$ e 3e $( (*e 7$( $e*e *e ,e -,*+$ e*+r4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C0 DB01 DILTIA=EMUM COMPR4 K0 DILTIA=EM AL@ALOID K0 K0 AL@ALOID DOODILTIA=EM EIPICO K0 K0 E4I4P4I4CO4 MED S4R4L4DILTIA=EM LP) K0 K0 LABORMED P)ARMA SA


30/485

DIL=EM K0 K0 PFI=ER EUROPE MA EEI;

C0 DB01 DILTIA=EMUM COMPR4 90 DILTIA=EM AL@ALOID 90 90 AL@ALOID DOO

C0 DB01 DILTIA=EMUM COMPR4 FILM4 ELIB4 90 PREL4DIL=EM 90 RETARD 90 PFI=ER EUROPE MA EEI;________________________________________________________________________________

______________________________________________________________________________| |C09AA01| CAPTOPRILUM | ||_______|_______|____________________________________________|_________________|

U "*"7 re " "," +r"*+r e 7" e*+r #e $+ /er3"e "+ e 3" e" " !(*3 r$" "" e3 e $+ r " #"$ #e+ re$e e#"$ e e*e #" $e 3 $ e +r"e ( &+3

3+$" e $( + r e & (*(" " ( er+4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C09AA01 CAPTOPRILUM COMPR4 125 CAPTOPRIL MCC 125 125 MA;ISTRA C < C

C09AA01 CAPTOPRILUM COMPR4 124 CAPTOPRIL 125 124 E;IS P)ARMACEUTICALS LTD4

C09AA01 CAPTOPRILUM COMPR4 2 CAPTOPRIL-AC 2 2 AC )ELCOR P)ARMA SRLCAPTOPRIL SINTOFARM 2 2 SINTOFARM SACAPTOPRIL 2 EEL 2 BIO EEL SRLCAPTOPRIL 2 2 E;IS P)ARMACEUTICALS LTD4CAPTOPRIL LP) 2 2 LABORMED P)ARMA SACAPTOPRIL MCC 2 2 MA;ISTRA C < C

C09AA01 CAPTOPRILUM COMPR4 0 CAPTOPRIL 0 0 ARENA ;ROUP SA

C09AA01 CAPTOPRILUM COMPR4 0 CAPTOPRIL-AC 0 0 AC )ELCOR P)ARMA SRLCAPTOPRIL 0 EEL 0 BIO EEL SRLCAPTOPRIL 0 0 E;IS P)ARMACEUTICALS LTD4CAPTOPRIL LP) 0 0 LABORMED P)ARMA SACAPTOPRIL MCC 0 0 MA;ISTRA C < C________________________________________________________________________________

______________________________________________________________________________| G |C09AA02| ENALAPRILUM | ||_______|_______|____________________________________________|_________________|


3+$" e $( + r e & (*(" " ( er+4


31/485

Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C09AA02 ENALAPRILUM SOL4 IN 4 142 8 *ENAP R 142 8 * @R@A D4D4

C09AA02 ENALAPRILUM COMPR4 10 EDN T R 10 10 ;EDEON RIC)TER LTD4ENA)E>AL R 10 10 )E>AL A;ENALA TAD 10 10 TAD P)ARMA ;MB)ENALAP 10 E4I4P4I4CO4 MED S4R4L4ENALAPRIL 10 10 MA;ISTRA C < CENALAPRIL AL 10 10 ALIUD R P)ARMA ;MB) < CO4@;ENALAPRIL FABIOL 10 10 FABIOL SA

ENALAPRIL LP) 10 10 LABORMED P)ARMA SAENALAPRIL SANDO= 10 10 SANDO= SRLENALAPRIL TERAPIA 10 10 TERAPIA SAENAM 10 10 REPRE=ENTANTA DR4 REDD JS LABORATORIES LTD4ENAP 10 10 @R@A D4D4 NOVO MESTORENITEC 10 10 MERC@ S)ARP < DO)ME ROMANIA S4R4L4

C09AA02 ENALAPRILUM COMPR4 24 EDN T R 25 24 ;EDEON RIC)TER LTD4

C09AA02 ENALAPRILUM COMPR4 20 EDN T R 20 20 ;EDEON RIC)TER LTD4ENA)E>AL R 20 20 )E>AL A;ENALA TAD 20 20 TAD P)ARMA ;MB)ENALAPRIL 20 O=ONE LABORATORIES LTD4ENALAPRIL 20 20 MA;ISTRA C < CENALAPRIL AL 20 20 ALIUD R P)ARMA ;MB) < CO4@;ENALAPRIL FABIOL 20 20 FABIOL SAENALAPRIL LP) 20 20 LABORMED P)ARMA SAENALAPRIL SANDO= 20 20 SANDO= SRLENALAPRIL TERAPIA 20 20 TERAPIA SAENAP 20 20 @R@A D4D4 NOVO MESTORENITEC 20 20 MERC@ S)ARP < DO)ME ROMANIA S4R4L4

C09AA02 ENALAPRILUM COMPR4 EDN T R ;EDEON RIC)TER LTD4ENA)E>AL R )E>AL A;ENALA TAD TAD P)ARMA ;MB)ENALAPRIL O=ONE LABORATORIES LTD4ENALAPRIL AL ALIUD R P)ARMA ;MB) < CO4@;ENALAPRIL LP) R LABORMED P)ARMA SAENALAPRIL SANDO= SANDO= SRL


32/485

ENAP @R@A D4D4 NOVO MESTORENITEC MERC@ S)ARP < DO)ME ROMANIA S4R4L4________________________________________________________________________________

______________________________________________________________________________| |C09AA0 | LISINOPRILUM | ||_______|_______|____________________________________________|_________________|




C09AA0 LISINOPRILUM COMPR4 10 LISI;AMMA 10 10 ?OR?A; P)ARMA ;MB) < CO4@;LISINOPRIL 10 MEDO 10 MEDOC)EMIE ROMANIA SRLLISINOPRIL ANTIBIOTICE 10 10 ANTIBIOTICE SALISINOPRIL SANDO= 10 10 )E>AL A;LISIREN 10 10 AC )ELCOR SRLMEDAPRIL 10 10 MEDOC)EMIE LTD4RANOLIP 10 RANBA> U4@4 LIMITEDSINOPR L R 10 10 EC=ACIBASI P)ARMACEUTICALS S4R4L4TONOL SIN 10 10 ;EDEON RIC)TER LTD4

C09AA0 LISINOPRILUM COMPR4 24 TONOL SIN 25 24 ;EDEON RIC)TER LTD4

C09AA0 LISINOPRILUM COMPR4 20 USI;AMMA 20 20 ?OR?A; P)ARMA ;MB) < CO4@;LISINOPRIL 20 MEDO 20 MEDOC)EMIE ROMANIA SRLLISINOPRIL ANTIBIOTICE 20 20 ANTIBIOTICE SALISINOPRIL SANDO= 20 20 )E>AL A;LISIREN 20 20 AC )ELCOR SRLMEDAPRIL 20 20 MEDOC)EMIE LTD4RANOLIP 20 RANBA> U4@4 LIMITEDTONOL SIN 20 20 ;EDEON RIC)TER LTD4

C09AA0 LISINOPRILUM COMPR4 G0 LISINOPRIL ANTIBIOTICE G0 G0 ANTIBIOTICE SA

C09AA0 LISINOPRILUM COMPR4 LISI;AMMA ?OR?A; P)ARMA ;MB) < CO4@;LISINOPRIL MEDO MEDOC)EMIE ROMANIA SRLLISINOPRIL SANDO= )E>AL A;MEDAPRIL MEDOC)EMIE LTD4RANOLIP RANBA> U4@4 LIMITEDTONOL SIN ;EDEON RIC)TER LTD4________________________________________________________________________________


33/485

______________________________________________________________________________| K |C09AA0 | RAMIPRILUM | ||_______|_______|____________________________________________|_________________|



________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C09AA0 RAMIPRILUM COMPR4 FILM4 142 RAMIRAN 152 142 RANBA> U4@4 LIMITED

C09AA0 RAMIPRILUM COMPR4 10 EMREN 10 10 ;EDEON RIC)TER ROMANIA

S4A4VIVACE 10 10 ACTAVIS ;ROUP )F

C09AA0 RAMIPRILUM COMPR4 10 AMPRIL 10 10 @R@A D4D4 NOVO MESTOPIRAMIL 10 10 SANDO= SRLRAMI;AMMA 10 10 ?OR?A; P)ARMA ;MB) < CO4@;RAMIPRIL-AC 10 10 AC )ELCOR P)ARMA SRLTRITACE 10 10 SANOFI-AVENTIS DEUTSC)LAND ;MB)=ENRA 10 10 =ENTIVA S4A4

C09AA0 RAMIPRILUM COMPR4 FILM4 10 RAMIRAN 10 10 RANBA> U4@4 LIMITED

C09AA0 RAMIPRILUM COMPR4 25 EMREN 25 25 ;EDEON RIC)TER ROMANIA S4A4VIVACE 25 25 ACTAVIS ;ROUP )F

C09AA0 RAMIPRILUM COMPR4 24 AMPRIL 25 24 @R@A D4D4 NOVO MESTOPIRAMIL 25 24 SANDO= SRLRAMIPRIL-AC 25 24 AC )ELCOR P)ARMA SRLTRITACE R 25 24 AVENTIS P)ARMA DEUTSC)LAND ;MB)=ENRA 25 24 =ENTIVA S4A4

C09AA0 RAMIPRILUM COMPR4 FILM4 24 RAMIRAN 25 24 RANBA> U4@4 LIMITED

C09AA0 RAMIPRILUM COMPR4 EMREN ;EDEON RIC)TER ROMANIA S4A4VIVACE ACTAVIS ;ROUP )F

C09AA0 RAMIPRILUM COMPR4


34/485

AMPRIL @R@A D4D4 NOVO MESTOPIRAMIL SANDO= SRLRAMI;AMMA ?OR?A; P)ARMA ;MB) < CO4@;RAMIPRIL-AC AC )ELCOR P)ARMA SRLTRITACE R AVENTIS P)ARMA DEUTSC)LAND ;MB)=ENRA =ENTIVA S4A4

C09AA0 RAMIPRILUM COMPR4 FILM4 RAMIRAN RANBA> U4@4 LIMITED________________________________________________________________________________

______________________________________________________________________________| |C09AA0K| UINAPRILUM | ||_______|_______|____________________________________________|_________________|


3+$" e $( + r e & (*(" " ( er+4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"

$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C09AA0K UINAPRILUM COMPR4 FILM4 10

UINAPRIL SANDO= 10 10 )E>AL A;

C09AA0K UINAPRILUM COMPR4 FILM4 10 ACCUPRO 10 10 PFI=ER EUROPE MA EEI;A UIRIL 10 10 LABORMED P)ARMA SA

UINARAN 10 10 RANBA> U@ LIMITED

C09AA0K UINAPRILUM COMPR4 FILM4 20 UINAPRIL SANDO= 20 20 )E>AL A;

C09AA0K UINAPRILUM COMPR4 FILM4 20 ACCUPRO R 20 20 PFI=ER EUROPE MA EEI;

UINARAN 20 20 RANBA> U@ LIMITED

C09AA0K UINAPRILUM COMPR4 FILM4 G0 UINAPRIL SANDO= G0 G0 )E>AL A;

C09AA0K UINAPRILUM COMPR4 FILM4 G0 UINARAN G0 G0 RANBA> U@ LIMITED

C09AA0K UINAPRILUM COMPR4 FILM4 UINAPRIL SANDO= )E>AL A;

C09AA0K UINAPRILUM COMPR4 FILM4 ACCUPRO R PFI=ER EUROPE MA EEI;

UINARAN RANBA> U@ LIMITED________________________________________________________________________________

______________________________________________________________________________


35/485

| |C09AA09| FOSINOPRILUM | ||_______|_______|____________________________________________|_________________|



________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C09AA09 FOSINOPRILUM COMPR4 10 FOSINOPRIL TERAPIA 10 10 TERAPIA SAFOS PRIL 10 10 TERAPIA S4A4MONOPRIL 10 10 BRISTOL M ERS S UIBB @FT

C09AA09 FOSINOPRILUM COMPR4 20

FOSINOPRIL TERAPIA 20 20 TERAPIA SAFOSINOPRIL TEVA 20 20 TEVA P)ARMACEUTICAL S4R4L4FOS PRIL 20 20 TERAPIA SA4MONOPRIL 20 20 BRISTOL-M ERS S UIBB @FT________________________________________________________________________________

______________________________________________________________________________| 9 |C09BA02| COMBINAŢII ENALAPRILUM | || | | ) DROC)LOROT)IA=IDUM | ||_______|_______|____________________________________________|_________________|



________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C09BA02 COMBINAŢII COMPR4 10 82

ENALAPRILUM 10 82 )E>AL A;) DROC)LOROT)IA=IDUMENALAPRIL )CT SANDO=10 82

C09BA02 COMBINAŢII COMPR4 10 124 ENALAPRILUM

) DROC)LOROT)IA=IDUMENAP )L 10 124 @R@A D4D4 NOVO MESTO


) DROC)LOROT)IA=IDUMENAP ) 10 2 @R@A D4D4 NOVO MESTO


36/485


) DROC)LOROT)IA=IDUMENAP R )L 20 8125 20 8124 @R@A D4D4 NOVO MESTO

C09BA02 COMBINAŢII COMPR4 20 8124 ENALAPRILUM 20 8124 )E>AL A;

) DROC)LOROT)IA=IDUMENALAPRIL )CT SANDO=20 8125

C09BA02 COMBINAŢII COMPR4ENALAPRILUM

) DROC)LOROT)IA=IDUMVIMAPRIL ) VIM SPECTRUM SRLVIMAPRIL )L VIM SPECTRUM SRL________________________________________________________________________________

______________________________________________________________________________

| K0 |C09BA0 | COMBINAŢII RAMIPRILUM | || | | ) DROC)LOROT)IA=IDUM | ||_______|_______|____________________________________________|_________________|



________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C09BA0 COMBINAŢII COMPR4 24 8124

RAMIPRILUM ) DROC)LOROT)IA=IDUM)ARTIL )CT 25 8125 24 8124 E;IS P)ARMACEUTICALS PLCPIRAMIL )CT 25 8125 24 8124 )E>AL A;RAMIPRIL )CT-MEDOC)EMIE 24 8124 MEDOC)EMIE LTD4

C09BA0 COMBINAŢII COMPR4 24 124 RAMIPRILUM

) DROC)LOROT)IA=IDUMAMPRIL )L 24 124 @R@A D4D4 NOVO MESTO

C09BA0 COMBINAŢII COMPR4 82 RAMIPRILUM ) DROC)LOROT)IA=IDUM)ARTIL )CT 82 82 E;IS P)ARMACEUTICALS PLCPIRAMIL )CT 82 82 )E>AL A;RAMIPRIL )CT-MEDOC)EMIE 82 MEDOC)EMIE LTD4

C09BA0 COMBINAŢII COMPR4 2 RAMIPRILUM

) DROC)LOROT)IA=IDUM


37/485

AMPRIL )D 2 @R@A D4D4 NOVO MESTO________________________________________________________________________________

______________________________________________________________________________| K1 |C09CA01| LOSARTANUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C09CA01 LOSARTANUM COMPR4 FILM4 0 CO=AAR 0 MERC@ S)ARP < DO)ME ROMANIA S4R4L4________________________________________________________________________________

______________________________________________________________________________| K2 |C10AA01| SIMVASTATINUM | Pr+ +$+*: CE01E ||_______|_______|____________________________________________|_________________|

Pre3$r"ere *" " : Se ( "*"7e 7 !e r( ! $"e '"" $ re #e!*" e3$ $r" er""*e#e e*" ","*" e 3 ,"*" e !r" Pr+ +$+*(* #e !re3$r"ere e#"$ e e*+r

"!+*"!e " e4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C10AA01 SIMVASTATINUM COMPR4 FILM4 10 SIMVASTATIN 10 10 TERAPIA S4A4

C10AA01 SIMVASTATINUM COMPR4 FILM4 10 SIM;AL R 10 10 IVA>-P)ARMACEUTICALS S4R4O4SIMVA TAD 10 10 TAD P)ARMA ;MB)SIMVACARD R 10 10 =ENTIVA ASSIMVA;AMMA 10 10 ?OR?A; P)ARMA ;MB) < CO4@;SIMVA)E>AL R 10 10 )E>AL A;SIMVASTATIN LP) 10 10 LABORMED P)ARMA SASIMVOR 10 10 RANBA> U4@4 LIMITEDSINTENAL 10 10 AC )ELCOR P)ARMA SRLVABADIN 10 10 MENARINI INTERNATIONAL OPERATIONS LU>EMBUR; S4A4VASILIP 10 10 @R@A D4D4=AREDIL 10 10 O=ONE LABORATORIES LTD4=EPLAN R 10 10 ;EDEON RIC)TER ROMANIA SA=OCOR 10 10 MERC@ S)ARP < DO)ME ROMANIA S4R4L4

C10AA01 SIMVASTATINUM COMPR4 FILM4 20 SIMVASTATIN 20 20 TERAPIA S4A4

C10AA01 SIMVASTATINUM COMPR4 FILM4 20


38/485


39/485


________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C10AA02 LOVASTATINUM COMPR4 20 MEDOSTATIN 20 MEDOC)EMIE LTD4________________________________________________________________________________

______________________________________________________________________________| KG |C10AA0 | PRAVASTATINUM | Pr+ +$+*: CE01E ||_______|_______|____________________________________________|_________________|


"!+*"!e " e4 Se !*"$ ( (r+r #e ( "r"*+r $+ er$" *e5 &+r e*+r & r $e( "$e 6"

$+ $e r '""*+r $+re3!( 7 + re DCI-(*("4________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C10AA0 PRAVASTATINUM COMPR4 10 PRALIP 10 10 SANDO= SRLPRAVATOR 10 10 RANBA> U4@4 LIMITED

C10AA0 PRAVASTATINUM COMPR4 20 PRALIP 20 20 SANDO= SRLPRAVATOR 20 20 RANBA> U4@4 LIMITED

C10AA0 PRAVASTATINUM COMPR4 G0 PRALIP G0 G0 SANDO= SRLPRAVATOR G0 G0 RANBA> U4@4 LIMITED________________________________________________________________________________

______________________________________________________________________________| K |C10AB0 | FENOFIBRATUM | Pr+ +$+*: CE01E ||_______|_______|____________________________________________|_________________|


"!+*"!e " e4

NOTĂ: R"3$(* #e +H"$" e (3$(* r 3e/er $re6 e # $ &e +&",r ( e3 e ( "*"73" (* $( " "," +r" #e )M; C+A re#($ 7 3 ( *'" &",r '"4 Ter !" $+ ,"

re,("e &+*+3" $( !re$ ('"e * ! $"e '"" $( #"3*"!"#e "e "H 3e/er $+ ," $(r"3$ $ r#"+/ 3$(* r * 5 ,3e ' e$e#e e*+r #e &e$'"( e (3$(* r 4P $"e '"" /+r &" + " +r"7 '" re (* !e r( 3e e $r+ "$e #e +H"$" e (3$(* r 4



40/485

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________C10AB0 FENOFIBRATUM CAPS4 100 LIPANT) L R 100 100 LAB4 FOURNIER SA

C10AB0 FENOFIBRATUM CAPS4 1K0 LIPOFIB 1K0 1K0 TERAPIA S4A4

C10AB0 FENOFIBRATUM COMPR4 FILM4 ELIB4 1K0 MODIF4LIPANT) L R SUPRA 1K0 1K0 LAB4 FOURNIER SA

C10AB0 FENOFIBRATUM CAPS4 200 LIPOFIB 200 200 TERAPIA S4A4

C10AB0 FENOFIBRATUM CAPS4 PULB4 MICRONI=ATĂ 200

FENOFIBRAT LP) 200 200 LABORMED P)ARMA SALIPANT) L 200 M 200 LAB4 FOURNIER SALIPIVIM 200 VIM SPECTRUM SRL________________________________________________________________________________

______________________________________________________________________________| KK |D01AC02| MICONA=OLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________D01AC02 MICONA=OLUM CREMĂ 20 8MICONAL ECOBI 20 8 FARMACEUTICI ECOBI S4A4S4

D01AC02 MICONA=OLUM CREMĂ 2%MEDACTER 2% FARAN LABORATORIES S4A4MICONA=OL NITRAT 2% 2% SLAVIA P)ARM SRL

D01AC02 MICONA=OLUM ;EL 2%DERMO=OL 2% P)ARCOIMPE> 9 S4R4L4________________________________________________________________________________

______________________________________________________________________________| K |D01AC10| BIFONA=OLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________D01AC10 BIFONA=OLUM SOL4 CUT4 0501 8 *M COSPOR 0501 8 * BA ER )EALT)CARE A;


41/485

D01AC10 BIFONA=OLUM CREMĂ 100 M CO-FLUSEMIDON 100 ANFARM )ELLAS S4A4 P)ARMACEUTICALS

D01AC10 BIFONA=OLUM CREMĂ 10 8BIA=OL 10 8 10 8 ;EDEON RIC)TER ROMANIA SA

D01AC10 BIFONA=OLUM CREMĂ 1%M COSPOR 1% BA ER )EALT)CARE A;________________________________________________________________________________

______________________________________________________________________________| K |D0KBB0 | ACICLOVIRUM | ||_______|_______|____________________________________________|_________________|


D0KBB0 ACICLOVIRUM CREMĂ 0 8ACICLOVIR ) PERION 0 8 ) PERION S4A4ACI@LOVIR CREMĂ 0 8 A < ; MED TRADIN; S4R4L4

D0KBB0 ACICLOVIRUM CREMĂ %ACICLOVIR % O=ONE LABORATORIES LTD4ACICLOVIR % % ;EDEON RIC)TER ROMANIA SACLOVIRAL R % % ANTIBIOTICE SA=OVIRA> % T)E ?ELLCOME FOUNDATION LTD4________________________________________________________________________________

______________________________________________________________________________| K9 |D0 AA02| ) DROCORTISONUM | Pr+ +$+*: D001L ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________D0 AA02 ) DROCORTISONUM UN;UENT 1500%)IDROCORTI=ON 1% 1% ANTIBIOTICE SA________________________________________________________________________________

______________________________________________________________________________| 0 |D0 AC01| BETAMET)ASONUM | Pr+ +$+*: D001L ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________D0 AC01 BETAMET)ASONUM CREMĂ 05 8BELODERM CREMĂ 05 8 A < ; MED TRADIN; S4R4L4


42/485

D0 AC01 BETAMET)ASONUM UN;UENT 05 8BELODERM UN;UENT 05 8 A < ; MED TRADIN; S4R4L4

D0 AC01 BETAMET)ASONUM CREMĂ 041%BETADERM 041% E4I4P4I4CO4 MED S4R4L4

D0 AC01 BETAMET)ASONUM UN;UENT 041%BETADERM 041% E4I4P4I4CO4 MED S4R4L4________________________________________________________________________________

______________________________________________________________________________| 1 |;01AF0G| MICONA=OLUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________;01AF0G MICONA=OLUM CAPS4 MOI VA;4 142

MICONAL ECOBI 142 FARMACEUTICI ECOBI S4A4S;01AF0G MICONA=OLUM CREMĂ VA;4 20 8MICONALECOBI 20 8 FARMACEUTICI ECOBI S4A4S

;01AF0G MICONA=OLUM SOL4 VA;INALĂ 2 8 *MICONAL ECOBI 2 8 * FARMACEUTICI ECOBI S4A4S

;01AF0G MICONA=OLUM OVULE 0 MICONALECOBI 0 FARMACEUTICI ECOBI S4A4S

;01AF0G MICONA=OLUM CREMĂ VA;4 2%MEDACTER 2% FARAN LABORATORIES S4A4M CO)EAL 2% DAR AL DA?A P)ARMA S4R4L4________________________________________________________________________________

______________________________________________________________________________| 2 |;02AB0 | ER;OMETRINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________;02AB0 ER;OMETRINUM SOL4 IN 4 042 8 *MALEAT DE ER;OMETRINA 042 8 * =ENTIVA S4A4052 8 *________________________________________________________________________________

______________________________________________________________________________| |;0 BA0 | TESTOSTERONUM | ||_______|_______|____________________________________________|_________________|



43/485

CONCENTRAŢIE FIRMA________________________________________________________________________________;0 BA0 TESTOSTERONUM SOL4 IN 4 1000 8G *NEBIDO 1000 8G * 1000 8G * SC)ERIN; A;

;0 BA0 TESTOSTERONUM CAPS4 MOI G0 UNDESTO R TESTOCAPS R G0 OR;ANON NV

Pre3$r"ere *" " : De&"$" #r+ e "$ * , r, '" #e $ (7 !r" r e3 "$(* r3 ( 3e$( # r "!+ * +- "!+&"7 r $+ &"r !r" "/e* !* 3 "$ *

e3 +3 er+ (*(" * $e* !('" 2 #e er " r" #+( #" " e'" #"&er" e " "$ 3 (e * $( *" " " &er"+ r / *+r"*+r re $ "/(*(" ( "*"7 4 Pre3$r"ere *" " : M"$r+!e "35 " #($ere !(,er '"" 3 ( Qr7"ere$+ 3 " ('"+ * $re6 er"" 3 ( !(,er '"" * , "e'" 3(, 1 "4

;0 BA0 TESTOSTERONUM ;EL 0 ANDRO;EL 0 0 LAB4 BESINS INTERNATIONAL________________________________________________________________________________

______________________________________________________________________________

| G |;0 CA0 | ESTRADIOLUM | ||_______|_______|____________________________________________|_________________|

Pre3$r"ere *" " : U "*"7 3" ! + e*e $ r $ er"3 "$e !+3 - e +! (7e"5 $ 7(* $ re er !" e3 r+ e "$ #+7e re#(3e #e + 3 r " +*er ' *

# " "3 r re +r * $( e3 r+ e "4 A$e 3 *" " re e3 e / * ,"* #+ r !e r( &+r e*e & r $e( "$e S"3 e

er !e( "$ r 3#er "$ 6" !* 3 (re r 3#er "$4

NOTĂ: E3 r #"+* re,("e &+*+3" !re( $( ( !r+ e3 "/ +r * * &e e"*e

e "3 ere$ + "7 e4

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________;0 CA0 ESTRADIOLUM ;EL 040K%OESTRO;EL R 040K% LAB4 BESINS INTERNATIONAL

;0 CA0 ESTRADIOLUM ;EL 041%ESTREVA R 041% LAB4 T)ERAME>

;0 CA0 ESTRADIOLUM COMPR4 FILM4 1 ESTROFEM 1 1 NOVO NORDIS@ A8S

;0 CA0 ESTRADIOLUM COMPR4 VA;4 2 "$r+ r eVA;IFEM 2 "$r+ r e NOVO NORDIS@ A8S

;0 CA0 ESTRADIOLUM IMPLANT 2 RISELLE 2 2 OR;ANON NV

;0 CA0 ESTRADIOLUM PLASTURE TRANSDERM4 0 "$r+ r e82G +reCLIMARA 0 "$r+ r e82G +re SC)ERIN; A;________________________________________________________________________________


44/485

______________________________________________________________________________| |;0GCAN1| DO>A=OSINUM | ||_______|_______|____________________________________________|_________________|

________________________________________________________________________________DCI8DENUMIRE COMERCIALĂ FORMA FARM4 __________________________________________________ CONCENTRAŢIE FIRMA________________________________________________________________________________;0GCAN1 DO>A=OSINUM COMPR4 1 DO>A=OSIN 1 MEDOC)EMIE 1 MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL 1 1 ALIUD R P)ARMA ;MB) < CO4@;@AMIREN 1 @R@A D4D4 NOVO MESTOMA;UROL 1 MEDOC)EMIE LTD4

;0GCAN1 DO>A=OSINUM COMPR4 2 DO>A=OSIN 2 MEDOC)EMIE 2 MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL 2 2 ALIUD R P)ARMA ;MB) < CO4@;

DO>A=OSIN SANDO= 2 2 )E>AL A;@AMIREN 2 @R@A D4D4 NOVO MESTOMA;UROL 2 MEDOC)EMIE LTD4

;0GCAN1 DO>A=OSINUM COMPR4 G DO>A=OSIN G MEDOC)EMIE G MEDOC)EMIE ROMANIA SRLDO>A=OSIN AL G G ALIUD R P)ARMA ;MB) < CO4@;@AMIREN G @R@A D4D4 NOVO MESTOMA;UROL G MEDOC)EMIE LTD4

;0GCAN1 DO>A=OSINUM COMPR4 ELIB4 MODIF4 G CARDURA >L G G PFI=ER )4C4P4 CORPORATION

;0GCAN1 DO>A=OSINUM COMPR4 FILM4 ELIB4 G PREL4@AMIREN >L G G @R@A D4D4 NOVO MESTO

;0GCAN1 DO>A=OSINUM COMPR4 1 DO>A=OSIN 1

81_95_ordin Nr 1301-500 Partea II

Documents

Transcript of 81_95_ordin Nr 1301-500 Partea II